Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam and Promethazine for Pediatric Dental Sedation
NCT01118884Phase 3Unknown
- Sponsor
- Shahid Beheshti University
- Start
- Jun 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of promethazine in Dental anxiety, sponsored by Shahid Beheshti University. Primary endpoint: Behavior change during dental treatment at 30 months. Status: unknown.
02
Drugs
promethazine
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on NCT01118884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01118884.